Combination of everolimus with sorafenib for solid renal tumors in Tsc2+/- mice is duperior to everolimus alone by Yang, J, Samsel, PA, Narov, K, Jones, A, Gallacher, D, Gallacher, J, Sampson, JR, Shen, MH